| Clinical characteristics and predictors of progression of chronic kidney disease in autosomal dominant polycystic kidney disease: a single center experience A Ozkok, TS Akpinar, F Tufan, NA Kanitez, M Uysal, M Guzel, Y Caliskan, ... Clinical and experimental nephrology 17, 345-351, 2013 | 70 | 2013 |
| Short Tandem Repeat-Polymerase Chain Reaction (STR-PCR) with Quantitative Real Time-Polymerase Chain Reaction (qRT-PCR) Method Using for Chimerism Analysis. F Abatay-Sel, F Savran-Oguz, S Kalayoglu-Besisik, M Mastanzade, ... Clinical Laboratory 65 (9), 2019 | 7 | 2019 |
| A cross-sectional study to assess the prevalence of pancreatic exocrine insufficiency among diabetes mellitus patients in Turkey K Demir, C Karaca, E Ahishali, M Mestanzade, S Celik, N Gul, F Turker, ... Pancreas 45 (7), e39-e40, 2016 | 7 | 2016 |
| Case report: Severe COVID-19 pneumonia in a patient with relapsed/refractory Hodgkin’s lymphoma I Yonal-Hindilerden, F Hindilerden, M Mastanzade, TO Tiryaki, ... Frontiers in Oncology 11, 601709, 2021 | 5 | 2021 |
| Patterns of Hydroxyurea Prescription and Use in Routine Clinical Management of Polycythemia Vera: A Multicenter Chart Review Study Y Büyükaşık, R Ali, M Turgut, G Saydam, AS Yavuz, A Ünal, MC Ar, ... Turkish Journal of Hematology 37 (3), 177, 2020 | 5 | 2020 |
| Cytomegalovirus reactivation during adult acute lymphoblastic leukemia maintenance: do we underestimate (un) expected guest of pediatric approach? M Ozbalak, MG Mastanzade, E Gurel, SK Besisik American Journal of Blood Research 11 (1), 118, 2021 | 3 | 2021 |
| Raman tweezers as an alternative diagnostic tool for paroxysmal nocturnal hemoglobinuria KB Soysal, S Parlatan, M Mastanzade, M Ozbalak, MN Yenerel, MB Unlu, ... Analytical Methods 13 (35), 3963-3969, 2021 | 2 | 2021 |
| R-CHOP chemotherapy including biosimilar rituximab (Redditux®) for de-novo diffuse large B-cell lymphoma patients: real-life single center experience M Ozbalak, M Mastanzade, O Ozluk, TO Tiryaki, S Erdem, EP Özbalak, ... Blood 138, 4585, 2021 | 1 | 2021 |
| R-CHOP Chemotherapy with a Rituximab Biosimilar (Redditux®) for Patients with de novo Diffuse Large B-cell Lymphoma: First Preliminary Results of a RealLife Single-Center … M Özbalak, M Mastanzade, Ö Özlük, TO Tiryaki, EP Özbalak, ... COMPREHENSIVE MEDICINE 13 (3), 194-198, 2021 | 1 | 2021 |
| A RARE CAUSE OF CYANOSIS: HEMOGLOBIN KANSAS M Mastanzade, A Koç, MH Demirbaş, S Özen Hematology, Transfusion and Cell Therapy 45, S40-S41, 2023 | | 2023 |
| P-425 Cardiac AL amyloidosis experienced in the last decade from a single center S Erdem, MG Mastanzade, PK Ozer, O Cetin, AC Hacialioglu, M Aydogan, ... Clinical Lymphoma Myeloma and Leukemia 23, S275, 2023 | | 2023 |
| P-432 Nasopharyngeal plasmacytoma with tumefactive amyloidosis (“amyloidoma”) presenting with unilateral hearing loss E Sakci, MG Mastanzade, B Sen, Z Sakci, IY Hindilerden, ... Clinical Lymphoma Myeloma and Leukemia 23, S279, 2023 | | 2023 |
| CLL-079 The Effect of T-Lymphocyte Subgroups at Diagnosis on the Prognosis of Chronic Lymphocytic Leukemia (CLL) D Seyithanoglu, E Nazligul, M Ozbalak, M Mastanzade, S Erdem, ... Clinical Lymphoma Myeloma and Leukemia 23, S319-S320, 2023 | | 2023 |
| POSTER: CLL-079 The Effect of T-Lymphocyte Subgroups at Diagnosis on the Prognosis of Chronic Lymphocytic Leukemia (CLL) D Seyithanoglu, E Nazligul, M Ozbalak, M Mastanzade, S Erdem, ... Clinical Lymphoma Myeloma and Leukemia 23, S171, 2023 | | 2023 |
| MPN-229 A Case of May Hegglin Anomaly With Pregnancy M Mastanzade, A Koç Clinical Lymphoma Myeloma and Leukemia 23, S387, 2023 | | 2023 |
| Biosimilar Rituximab (Redditux) Added to CHOP Chemotherapy for De Novo Diffuse Large B-Cell Lymphoma Patients: Real-Life Single-Center Experience M Özbalak, MG Mastanzade, Ö Özlük, TO Tiryaki, S Erdem, EP Özbalak, ... Turkish Journal of Hematology 39 (4), 254, 2022 | | 2022 |
| A CASE OF FASCIOLOSIS PRESENTING WITH SEVERE HYPEREOSINOPHILIA M Mastanzade, A Şenol, A Koç Hematology, Transfusion and Cell Therapy 44, S35, 2022 | | 2022 |
| P1620: RED CELL ALLOIMMUNIZATION IN MULTI-TRANSFUSED TURKISH PATIENTS WITH HEMATOLOGIC DISORDERS. S Oztaskin, M Yanasik, M Ozbalak, MG Mastanzade, O Ozluk, TO Tiryaki, ... HemaSphere 6, 1501-1502, 2022 | | 2022 |
| An Interim Analysis of the Turkish Myeloma Registry Among the Patients Who Have Received up to Two Lines of Therapy OG Sevindik, ZN Ozkurt, C Boga, SK Besisik, Y Ipek, A Geduk, ... Blood 138 (Supplement 1), 4730-4730, 2021 | | 2021 |
| AN UNUSUAL SURVIVING HISTORY: MULTISYSTEM INVOLVEMENT UNTIL ADULT LIFE WITH NIEMANN PICK TYPE B Ö ÖZLÜK, MG MASTANZADE, ŞEN Beyza, SK BEŞIŞIK, B BALLYYEV Hematology, Transfusion and Cell Therapy 43, S20, 2021 | | 2021 |
